| Name | PQ-912 |
|---|
| Description | PQ-912 is a competitive inhibitor of the enzyme glutaminyl cyclase[1]. PQ-912 inhibits human, rat, and mouse glutaminyl cyclase activity, with Ki values ranging between 20 and 65 nM[2]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 25 nM (human glutaminyl cyclase, pH:8.0); 65 nM (Mouse glutaminyl cyclase; pH:8.0)[2] |
| In Vivo | PQ-912 (oral treatment; 200 mg/kg/day for 1 week in hAPPSLxhQC double-transgenic mice) shows a significant reduction of pE-Aβ levels[2]. Animal Model: hAPPSLxhQC double-transgenic mice[2] Dosage: 200 mg/kg Administration: Oral treatment; daily for 1 week Result: Showed a significant reduction of pE-Aβ levels. |
| References |
| Molecular Formula | C19H20N4O2 |
|---|---|
| Molecular Weight | 336.39 |
| Storage condition | 2-8°C |
| Hazard Codes | Xn |
|---|